论文部分内容阅读
随着早产儿中心,围产期中心在日本全国各地的开设以及人工表面治性物质的开发为起点的呼吸监测的进步,早产儿生存率大大提高。作为保育对象的患儿出生体重年年下降,因此在早产儿医疗方面,对感染病症的治疗,变得比以前更为重要。一、独协医科大学病院早产儿部的MRSA感染实况本院早产儿部的治疗对象是低于正常出生体重(出生体重不足2500g)的早产儿和有疾病的成熟新生儿。而早产儿的败血症是指从两瓶或一瓶血液培养瓶中分离出病原菌,而临床症状及检查结果都可以明显显示有感染存在的病症,(不包括有些在临床上病原菌不明的败血症)。而MRSA是根据本院中心化验
With the progress of respiratory monitoring starting from the premature infant center and the perinatal center throughout Japan and the development of artificial surface-treating substances, the survival rate of preterm children is greatly increased. Since the birth weight of children under childcare is declining year after year, the treatment of infectious diseases in the medical care of premature infants has become more important than before. First, the Department of Premedication Medical University hospital premature infants MRSA infection live in our hospital premature infants Department of treatment is lower than the normal birth weight (birth weight less than 2500g) of premature children and the disease of mature newborn. Sepsis in premature infants refers to the isolation of pathogens from two or one bottle of blood culture bottles. The clinical symptoms and test results can clearly show the presence of infection (not including some clinically unknown sepsis). The MRSA is based on the hospital center test